When the cells were treated with the UQCRB inhibitor A1938, proliferation was also inhibited in a dose-dependent manner in the mutant UQCRB-expressing cells (Fig. 4g) and colon cancer cells (Fig. 4h). This evidence concerns the gene UQCRB and colonic neoplasm.